313 related articles for article (PubMed ID: 25225963)
1. Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors.
Egaña-Gorroño L; Escribà T; Boulanger N; Guardo AC; León A; Bargalló ME; Garcia F; Gatell JM; Plana M; Arnedo M;
PLoS One; 2014; 9(9):e106360. PubMed ID: 25225963
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression.
Egaña-Gorroño L; Guardo AC; Bargalló ME; Planet E; Vilaplana E; Escribà T; Pérez I; Gatell JM; García F; Arnedo M; Plana M M;
PLoS One; 2016; 11(5):e0155245. PubMed ID: 27171002
[TBL] [Abstract][Full Text] [Related]
3. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.
Witwer KW; Watson AK; Blankson JN; Clements JE
Retrovirology; 2012 Jan; 9():5. PubMed ID: 22240256
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts.
Duskova K; Nagilla P; Le HS; Iyer P; Thalamuthu A; Martinson J; Bar-Joseph Z; Buchanan W; Rinaldo C; Ayyavoo V
BMC Infect Dis; 2013 May; 13():250. PubMed ID: 23721325
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Expression Pattern of 4 microRNAs and their Correlation with Cellular/viral Factors in PBMCs of Long Term Non-progressors and HIV Infected Naïve Individuals.
Jamshidi S; Bokharaei-Salim F; Nahand JS; Monavari SH; Moghoofei M; Garshasbi S; Kalantari S; Esghaei M; Mirzaei H
Curr HIV Res; 2022; 20(1):42-53. PubMed ID: 34493187
[TBL] [Abstract][Full Text] [Related]
6. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker.
Yousefpouran S; Mostafaei S; Manesh PV; Iranifar E; Bokharaei-Salim F; Nahand JS; Mirzaei H; Taran M; Babaei F; Sayad B; Moghoofei M
Microb Pathog; 2020 Oct; 147():104355. PubMed ID: 32569788
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro.
Reynoso R; Laufer N; Hackl M; Skalicky S; Monteforte R; Turk G; Carobene M; Quarleri J; Cahn P; Werner R; Stoiber H; Grillari-Voglauer R; Grillari J
Sci Rep; 2014 Aug; 4():5915. PubMed ID: 25081906
[TBL] [Abstract][Full Text] [Related]
8. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers.
Zhang W; Ambikan AT; Sperk M; van Domselaar R; Nowak P; Noyan K; Russom A; Sönnerborg A; Neogi U
EBioMedicine; 2018 Jan; 27():40-50. PubMed ID: 29269040
[TBL] [Abstract][Full Text] [Related]
10. Utility of Systematic Isolation of immune cell subsets from HIV-infected individuals for miRNA profiling.
Bargalló ME; Guardo AC; Maleno MJ; Miralles L; Egaña-Gorroño L; Escribà T; García F; Gatell JM; Arnedo M; Plana M
J Immunol Methods; 2017 Mar; 442():12-19. PubMed ID: 28039100
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA Expression Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1 Positive Individuals and Relationship with Different Levels of Viral Suppression.
Di Carlo D; Falasca F; Mazzuti L; Guerrizio G; Migliara G; Santori M; Lazzaro A; Mezzaroma I; D'Ettorre G; Fimiani C; Iaiani G; Antonelli G; Turriziani O
AIDS Res Hum Retroviruses; 2024 May; 40(5):321-329. PubMed ID: 37523231
[TBL] [Abstract][Full Text] [Related]
12. MiRNA expression profiling in HIV pathogenesis, disease progression and response to treatment: a systematic review.
Leo CG; Mincarone P; Tumolo MR; Panico A; Guido M; Zizza A; Guarino R; De Santis G; Sedile R; Sabina S
Epigenomics; 2021 Oct; 13(20):1653-1671. PubMed ID: 34693727
[TBL] [Abstract][Full Text] [Related]
13. Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a
Sperk M; Ambikan AT; Ray S; Singh K; Mikaeloff F; Diez RC; Narayanan A; Vesterbacka J; Nowak P; Sönnerborg A; Neogi U
J Virol; 2021 Aug; 95(18):e0047921. PubMed ID: 34232744
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.
Goujard C; Girault I; Rouzioux C; Lécuroux C; Deveau C; Chaix ML; Jacomet C; Talamali A; Delfraissy JF; Venet A; Meyer L; Sinet M;
Antivir Ther; 2012; 17(6):1001-9. PubMed ID: 22865544
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.
Munshi SU; Panda H; Holla P; Rewari BB; Jameel S
PLoS One; 2014; 9(5):e95920. PubMed ID: 24828336
[TBL] [Abstract][Full Text] [Related]
16. Evidence for innate immune system activation in HIV type 1-infected elite controllers.
Krishnan S; Wilson EM; Sheikh V; Rupert A; Mendoza D; Yang J; Lempicki R; Migueles SA; Sereti I
J Infect Dis; 2014 Mar; 209(6):931-9. PubMed ID: 24185941
[TBL] [Abstract][Full Text] [Related]
17. RICH2 is implicated in viraemic control of HIV-1 in black South African individuals.
Paximadis M; Ngqobe RN; Chaisson RE; Martinson NA; Tiemessen CT
Infect Genet Evol; 2017 Apr; 49():78-87. PubMed ID: 28069446
[TBL] [Abstract][Full Text] [Related]
18. HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression.
Kammers K; Chen A; Monaco DR; Hudelson SE; Grant-McAuley W; Moore RD; Alter G; Deeks SG; Morrison CS; Eller LA; Blankson JN; Laeyendecker O; Ruczinski I; Eshleman SH; Larman HB
Front Immunol; 2021; 12():740395. PubMed ID: 34512672
[TBL] [Abstract][Full Text] [Related]
19. Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.
Buckheit RW; Allen TG; Alme A; Salgado M; O'Connell KA; Huculak S; Falade-Nwulia O; Williams TM; Gallant JE; Siliciano RF; Blankson JN
Nat Commun; 2012 Mar; 3():716. PubMed ID: 22395607
[TBL] [Abstract][Full Text] [Related]
20. HIV elite control is associated with reduced TRAILshort expression.
Paim AC; Cummins NW; Natesampillai S; Garcia-Rivera E; Kogan N; Neogi U; Sönnerborg A; Sperk M; Bren GD; Deeks S; Polley E; Badley AD
AIDS; 2019 Sep; 33(11):1757-1763. PubMed ID: 31149947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
